Antibody Structure and Function: The Basis for Engineering Therapeutics

Структура и функции антител: основа создания терапевтических препаратов
Gary L. Gilliland, A. Teplyakov, Mark L. Chiu, Dennis R. Goulet
2019-12-03

antibody engineeringantibody fragmentsantibody structure-function relationshipsbispecific antibodiestherapeutic biologics
Antibodies and antibody-derived macromolecules have established themselves as the mainstay in protein-based therapeutic molecules (biologics). Our knowledge of the structure-function relationships of antibodies provides a platform for protein engineering that has been exploited to generate a wide range of biologics for a host of therapeutic indications. In this review, our basic understanding of the antibody structure is described along with how that knowledge has leveraged the engineering of antibody and antibody-related therapeutics having the appropriate antigen affinity, effector function, and biophysical properties. The platforms examined include the development of antibodies, antibody fragments, bispecific antibody, and antibody fusion products, whose efficacy and manufacturability can be improved via humanization, affinity modulation, and stability enhancement. We also review the design and selection of binding arms, and avidity modulation. Different strategies of preparing bispecific and multispecific molecules for an array of therapeutic applications are included.
1
Antibody structure–function relationships provide the foundation for engineering diverse protein-based therapeutics across numerous clinical indications.
2
Binding-arm design, selection, and avidity modulation enable the development of bispecific and multispecific molecules for varied therapeutic applications.
3
Engineering platforms encompass full antibodies, antibody fragments, bispecific antibodies, and antibody fusion products.
4
Humanization, affinity modulation, and stability enhancement improve the efficacy and manufacturability of antibodies and antibody-derived molecules.
5
Protein engineering can tune antibody antigen affinity, effector function, and biophysical properties to improve therapeutic performance.

antibodies and antibody-derived macromolecules engineered as protein-based therapeutics

structure–function relationships and engineering of antibody-based therapeutics for antigen affinity, effector function, biophysical properties, efficacy, and manufacturability

Publication Details
Publication Date
2019-12-03
Journal
Publisher
ISSN
Cited by
728
Access Type
Author Information
Authors
Gary L. Gilliland
A. Teplyakov
Mark L. Chiu
Dennis R. Goulet
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%